TGA Approval

TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial (391176)

ARTG ID

391176

ARTG Name

TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial

Sponsor

BeiGene AUS Pty Ltd

ARTG Date

May 30, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BEIGENE AUS PTY LTD

https://medical-cdn.nocode.com/drug_tga/fcd45a4fae0f18678988e5d8e42754d2.pdf

https://medical-cdn.nocode.com/drug_tga/5e28529f3ef2056a85e56ffb5fe74fdf.pdf

Ingredient Name

tislelizumab

Empowering clinical research with data-driven insights and AI-powered tools.

TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial (391176) - TGA 批准文号 | MedPath